N-acetyl cysteine has been a beloved ingredient for detox (and, yes, hangovers) since 1991—three years before DSHEA was passed with its “grandfathered” ingredients proviso. Still, the FDA says it approved it as a drug back in 1963 so it must be taken off the market. Amazon abided. But really now, a half-century later? Seriously?
Speaking of the FDA, regulatory guru Asa Waldstein tells you the No. 1 reason why you don’t want a Warning Letter. Hint: Follow the money.
Also this episode, get a tutorial on the ingredient of the year in the immune-health category, as voted on by a panel of judges at SupplySide West 2021 in Las Vegas last October. Differentiate your brand in the marketplace by using this gatekeeper branded ingredient that activates other immune cells.
Guests this week:
- The Co-Factors: Todd Runestad & Ola Lessard
- Law Dog Josh Long, Informa Legal Editor
- Asa Waldstein from Supplement Advisory Group
- Danielle Citrolo, PharmD, vice president of scientific and regulatory affairs at Kyowa Hakko US
For additional epsiodes, visit the Insider in the Afternoon home page.